OncoVista Innovative Therapies Inc (OVIT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
OncoVista Innovative Therapies Cash from Operations (TTM): -0.2644M for Sept. 30, 2015
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2015 | -0.2644M |
June 30, 2015 | -0.3179M |
March 31, 2015 | -0.2838M |
December 31, 2014 | -0.2324M |
September 30, 2014 | -0.1996M |
June 30, 2014 | -0.1658M |
March 31, 2014 | -0.1948M |
December 31, 2013 | -0.4668M |
September 30, 2013 | -0.7119M |
June 30, 2013 | -0.9839M |
March 31, 2013 | -1.380M |
December 31, 2012 | -1.554M |
September 30, 2012 | -1.615M |
June 30, 2012 | -1.796M |
March 31, 2012 | -1.713M |
December 31, 2011 | -1.609M |
September 30, 2011 | -1.475M |
June 30, 2011 | -0.9261M |
March 31, 2011 | -0.6484M |
December 31, 2010 | -0.555M |
Date | Value |
---|---|
September 30, 2010 | -0.3676M |
June 30, 2010 | -0.5569M |
March 31, 2010 | -0.5827M |
December 31, 2009 | -0.9112M |
September 30, 2009 | -1.558M |
June 30, 2009 | -2.535M |
March 31, 2009 | -2.869M |
December 31, 2008 | -3.862M |
September 30, 2008 | -4.129M |
June 30, 2008 | -3.615M |
March 31, 2008 | -4.006M |
December 31, 2007 | -2.880M |
September 30, 2007 | -4.644M |
June 30, 2007 | -4.116M |
March 31, 2007 | -3.310M |
December 31, 2006 | -2.892M |
September 30, 2006 | -0.2165M |
June 30, 2006 | -0.2004M |
March 31, 2006 | -0.098M |
December 31, 2005 | -0.1167M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
FluoroPharma Medical Inc | -0.8801M |
RenovaCare Inc | -4.126M |
Xeno Transplants Corp | -- |
Entia Biosciences Inc | -0.7151M |
Regenerx Biopharmaceuticals Inc | -0.8237M |